Compare iShares US Aerospace & Defense ETF (ITA) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares US Aerospace & Defense ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? iShares US Aerospace & Defense ETF trades at $206.55 (market cap $11.87B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.95 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 2.1× iShares US Aerospace & Defense ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while iShares US Aerospace & Defense ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares US Aerospace & Defense ETF for 19 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| ITA | RPRX | |
|---|---|---|
Market Cap | $11.87B | $25.27B |
Volume | 1,060,125 | 3,671,183 |
Sector | Sector/Thematic | Health |
52-Week High | $253.22 | $63.96 |
52-Week Low | $198.23 | $35.44 |
Typical Hold Time | 19 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares US Aerospace & Defense ETF
iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
